ABE Capital Partners, a private equity fund manager, agreed to invest in Quimunsa, a developer and manufacturer of biocides. Financial terms were not disclosed. “Quimunsa has demonstrated in recent years its ability to identify development and research pathways that have allowed it to position itself as an attractive platform to capture organically and inorganically the market growth. We trust that internationalization and the continuous evolution of products will continue to be the main avenue for future development," Manuel Blanco, ABE Capital Founding Partner.